As of 2025-07-21, the EV/EBITDA ratio of Pressure Biosciences Inc (PBIO) is -3.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PBIO's latest enterprise value is 28.64 mil USD. PBIO's TTM EBITDA according to its financial statements is -8.27 mil USD. Dividing these 2 quantities gives us the above PBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 14.6x | 12.4x |
| Forward P/E multiples | 12.7x - 15.9x | 14.4x |
| Fair Price | (2.18) - (2.43) | (2.27) |
| Upside | -544393.9% - -607634.9% | -566427.3% |
| Date | EV/EBITDA |
| 2025-06-12 | -3.48 |
| 2025-06-11 | -3.46 |
| 2025-06-04 | -3.49 |
| 2025-05-20 | -3.49 |
| 2025-05-14 | -3.49 |
| 2025-05-13 | -3.49 |
| 2025-05-12 | -3.49 |
| 2025-05-08 | -3.50 |
| 2025-05-02 | -3.48 |
| 2025-04-28 | -3.48 |
| 2025-04-22 | -3.48 |
| 2025-04-10 | -3.50 |
| 2025-04-09 | -3.50 |
| 2025-04-07 | -3.51 |
| 2025-04-02 | -3.49 |
| 2025-03-27 | -3.56 |